Ying Deng

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer

Xiaoshan Wang, Yifeng Bai, Vivek Verma et al. · JNCI Journal of the National Cancer Institute · 2022 · 255 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma

Jingbiao Chen, Jing Zhou, Sichi Kuang et al. · American Journal of Roentgenology · 2019 · 81 citations

Medicine, Oncology, Radiology +17

Single-Cell Transcriptomics Reveals Crucial Cell Subsets and Functional Heterogeneity Associated With Carotid Atherosclerosis and Cerebrovascular Events

Jinyun Tan, Yongjun Liang, Yang Zhou et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2023 · 43 citations · Full text

Life Sciences, Cell Biology, Immunology +17

rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expression

Ying Deng, Hansong Bai, Honglin Hu · Biochemical and Biophysical Research Communications · 2015 · 41 citations

Medicine, Cancer Biology, Oncology +11

<i>PLA2G16</i> is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer

Wei Xia, Hansong Bai, Ying Deng et al. · Journal of Cellular and Molecular Medicine · 2020 · 36 citations · Full text

Life Sciences, Biochemistry, Oncology +17